DAVID BALTIMORE

CIK 1185858 · last filed 2025-06-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.47M

Companies

3

Total Filings

51

Lifetime Open-Market Net

-$4.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Regulus Therapeutics Inc. (RGLS) Delisted Director 114,584 $8.16 $935.0K $20.8K 20 2025-06-27
AMGN Director 32,286 $355.20 $11.47M -$4.06M 24 2018-05-01
MEDI Director 0 $31.04 $0 $0 1 2007-06-19

Recent Filings · Page 4 of 6

51 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-04-28 AMGN Grant (A) +1,191 $0 EDGAR
2015-03-03 AMGN Sell (S) −3,647 -$579.0K EDGAR
2015-02-23 AMGN Mixed +3,647 -$120 EDGAR
2015-01-09 Grant (A) $0
2014-02-26 AMGN Mixed +2,485 -$15 EDGAR
2013-08-30 AMGN Mixed −5,492 -$502.5K EDGAR
2013-06-10 Regulus Therapeutics Inc. (RGLS) Delisted Grant (A) $0 EDGAR
2013-04-30 AMGN Grant (A) +1,845 $0 EDGAR
2013-03-01 AMGN Mixed -$82.4K EDGAR
2012-12-12 AMGN Mixed -$605.3K EDGAR
Showing 3140 of 51
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.